1,2-dimethylhydrazine decreases expression ISO RGD:733114 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC34A2 mRNA CTD PMID:22206623 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of SLC34A2 mRNA CTD PMID:21983209 17alpha-ethynylestradiol increases expression ISO RGD:733114 6480464 Ethinyl Estradiol results in increased expression of SLC34A2 mRNA CTD PMID:12072388 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC34A2 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC34A2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733114 6480464 Tetrachlorodibenzodioxin affects the expression of SLC34A2 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733114 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC34A2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC34A2 mRNA] CTD PMID:21215274 4-hydroxyphenyl retinamide increases expression ISO RGD:733114 6480464 Fenretinide results in increased expression of SLC34A2 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC34A2 mRNA CTD PMID:31881176 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SLC34A2 mRNA CTD PMID:20488242 all-trans-retinoic acid affects expression ISO RGD:733113 6480464 Tretinoin affects the expression of SLC34A2 mRNA CTD PMID:31600526 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC34A2 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:733113 6480464 aristolochic acid I results in decreased expression of SLC34A2 mRNA CTD PMID:33212167 arsane increases transport ISO RGD:733113 6480464 SLC34A2 protein results in increased transport of Arsenic CTD PMID:22214486 arsenic atom increases transport ISO RGD:733113 6480464 SLC34A2 protein results in increased transport of Arsenic CTD PMID:22214486 benzo[a]pyrene increases methylation ISO RGD:733113 6480464 Benzo(a)pyrene results in increased methylation of SLC34A2 exon, Benzo(a)pyrene results in increased methylation of SLC34A2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733113 6480464 Benzo(a)pyrene affects the methylation of SLC34A2 5' UTR CTD PMID:27901495 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC34A2 mRNA CTD PMID:18164116 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC34A2 mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC34A2 mRNA CTD PMID:35192832 bisphenol A increases methylation ISO RGD:733113 6480464 bisphenol A results in increased methylation of SLC34A2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:733114 6480464 bisphenol A results in increased expression of SLC34A2 mRNA CTD PMID:32156529 , PMID:34585602 bisphenol A increases expression ISO RGD:733113 6480464 bisphenol A results in increased expression of SLC34A2 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC34A2 gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC34A2 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases expression ISO RGD:733114 6480464 bisphenol A results in decreased expression of SLC34A2 mRNA CTD PMID:26063408 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SLC34A2 mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 calcitriol increases expression ISO RGD:733113 6480464 Calcitriol results in increased expression of SLC34A2 mRNA CTD PMID:26485663 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of SLC34A2 mRNA CTD PMID:30744511 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC34A2 mRNA CTD PMID:12851107 , PMID:32741897 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC34A2 mRNA CTD PMID:21865292 dextran sulfate multiple interactions ISO RGD:733114 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC34A2 mRNA CTD PMID:29950665 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of SLC34A2 mRNA CTD PMID:23153324 dimethylarsinic acid multiple interactions ISO RGD:733114 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA CTD PMID:34876320 dioxygen multiple interactions ISO RGD:733114 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC34A2 mRNA CTD PMID:30529165 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC34A2 mRNA CTD PMID:29391264 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC34A2 mRNA CTD PMID:32741897 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC34A2 mRNA CTD PMID:24793618 fonofos increases methylation ISO RGD:733113 6480464 Fonofos results in increased methylation of SLC34A2 promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:733113 6480464 Formaldehyde results in increased expression of SLC34A2 mRNA CTD PMID:27905399 fructose decreases expression EXP 6480464 Fructose results in decreased expression of SLC34A2 mRNA CTD PMID:18400728 fructose multiple interactions EXP 6480464 tungstate promotes the reaction [Fructose results in decreased expression of SLC34A2 mRNA], Vanadates promotes the reaction [Fructose results in decreased expression of SLC34A2 mRNA] CTD PMID:18400728 fructose affects expression EXP 6480464 Fructose affects the expression of SLC34A2 mRNA CTD PMID:15150374 fulvestrant increases methylation ISO RGD:733113 6480464 Fulvestrant results in increased methylation of SLC34A2 gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of SLC34A2 mRNA CTD PMID:26194646 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of SLC34A2 mRNA CTD PMID:23153324 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SLC34A2 mRNA CTD PMID:21396975 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of SLC34A2 mRNA CTD PMID:16629162 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of SLC34A2 mRNA CTD PMID:16629162 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 methotrexate decreases expression ISO RGD:733113 6480464 Methotrexate results in decreased expression of SLC34A2 mRNA CTD PMID:24449571 methylarsonic acid multiple interactions ISO RGD:733114 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA CTD PMID:34876320 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of SLC34A2 mRNA CTD PMID:30744511 mirex decreases expression EXP 6480464 Mirex results in decreased expression of SLC34A2 mRNA CTD PMID:23153324 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of SLC34A2 mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC34A2 mRNA CTD PMID:18164116 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 nevirapine decreases expression EXP 6480464 Nevirapine metabolite results in decreased expression of SLC34A2 mRNA CTD PMID:23947594 nickel atom increases expression ISO RGD:733113 6480464 Nickel results in increased expression of SLC34A2 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate decreases expression ISO RGD:733114 6480464 nickel sulfate results in decreased expression of SLC34A2 mRNA CTD PMID:16100012 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLC34A2 mRNA CTD PMID:33484710 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC34A2 mRNA CTD PMID:23439660 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC34A2 mRNA CTD PMID:30723492 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC34A2 mRNA CTD PMID:32680482 parathion increases methylation ISO RGD:733113 6480464 Parathion results in increased methylation of SLC34A2 promoter CTD PMID:22847954 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC34A2 mRNA CTD PMID:28511854 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SLC34A2 mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:733114 6480464 Phenobarbital affects the expression of SLC34A2 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:733114 6480464 pirinixic acid results in decreased expression of SLC34A2 mRNA CTD PMID:17426115 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC34A2 mRNA CTD PMID:32741897 pirinixic acid increases expression ISO RGD:733114 6480464 pirinixic acid results in increased expression of SLC34A2 mRNA CTD PMID:20813756 pravastatin decreases expression ISO RGD:733114 6480464 Pravastatin results in decreased expression of SLC34A2 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of SLC34A2 mRNA CTD PMID:27225895 propiconazole increases expression ISO RGD:733114 6480464 propiconazole results in increased expression of SLC34A2 mRNA CTD PMID:21278054 prothioconazole increases expression ISO RGD:733113 6480464 prothioconazole results in increased expression of SLC34A2 mRNA CTD PMID:35048155 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC34A2 mRNA CTD PMID:28374803 sodium arsenate multiple interactions ISO RGD:733114 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA CTD PMID:34876320 sodium arsenite multiple interactions ISO RGD:733114 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC34A2 mRNA CTD PMID:34876320 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of SLC34A2 mRNA CTD PMID:21865292 tamoxifen increases expression ISO RGD:733114 6480464 Tamoxifen results in increased expression of SLC34A2 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:733114 6480464 Tamoxifen affects the expression of SLC34A2 mRNA CTD PMID:20937368 terbufos increases methylation ISO RGD:733113 6480464 terbufos results in increased methylation of SLC34A2 promoter CTD PMID:22847954 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of SLC34A2 mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:733114 6480464 1 more ... CTD PMID:33848595 testosterone increases expression ISO RGD:733114 6480464 Testosterone deficiency results in increased expression of SLC34A2 mRNA CTD PMID:33848595 tetrachloroethene decreases expression ISO RGD:733114 6480464 Tetrachloroethylene results in decreased expression of SLC34A2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC34A2 protein CTD PMID:17544377 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC34A2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:733114 6480464 titanium dioxide results in increased expression of SLC34A2 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:733114 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC34A2 mRNA CTD PMID:29950665 tributylstannane decreases expression ISO RGD:733114 6480464 tributyltin results in decreased expression of SLC34A2 mRNA CTD PMID:31939706 trichloroethene decreases expression ISO RGD:733114 6480464 Trichloroethylene results in decreased expression of SLC34A2 mRNA CTD PMID:28973375 triclosan increases expression ISO RGD:733113 6480464 Triclosan results in increased expression of SLC34A2 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLC34A2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:733114 6480464 triptonide results in increased expression of SLC34A2 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SLC34A2 mRNA CTD PMID:21515302 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 tungstate multiple interactions EXP 6480464 tungstate promotes the reaction [Fructose results in decreased expression of SLC34A2 mRNA] CTD PMID:18400728 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of SLC34A2 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:733113 6480464 Valproic Acid results in decreased methylation of SLC34A2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:733113 6480464 Valproic Acid results in increased expression of SLC34A2 mRNA CTD PMID:26272509 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SLC34A2 mRNA CTD PMID:19015723 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of SLC34A2 mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO RGD:733114 6480464 squalestatin 1 results in decreased expression of SLC34A2 mRNA CTD PMID:27225895 zoledronic acid increases expression ISO RGD:733113 6480464 zoledronic acid results in increased expression of SLC34A2 mRNA CTD PMID:24714768